Retrospective Observational Study of Outcomes in HER2-Positive Metastatic Breast Cancer (mBC) Patients Treated with Ado-Trastuzumab Emtansine (T-DM1) and Subsequent Treatments After T-DM1 in the United States.
Drugs Real World Outcomes
; 10(2): 177-186, 2023 Jun.
Article
in En
| MEDLINE
| ID: mdl-36539672
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Observational_studies
Language:
En
Journal:
Drugs Real World Outcomes
Year:
2023
Document type:
Article
Affiliation country:
Estados Unidos
Country of publication:
Suiza